Inducen-Res

Aspergilla sp.Bacillus anthracis, Aspergilla sp., Aspergillus fumigatus, Bacillus anthracis, Bordetella holmesii, Bordetella pertussis, Burkholderia cepacian +Lipopolysaccharide/endotoxin, Burkholderia pseudomallei +Endotoxin/Lipopolysaccharides, Candida spp., Chlamydophila pneumoniae (Chlamydia pneumoniae), Clostridium botulinum, Coccidioides sp, Corynebacter tuberculostericum, Enterobacter hormaechei, Francisella tularensis + Lipopolysaccharide/Endotoxin, Glomus intraradices, Haemophilus influenzae, Legionella pneumophila, Mycobacteria Avium complex, Mycobacterium abcessus, Mycobacterium intracellularis, Mycobacterium kansasii, Mycobacterium tuberculosis, Mycobacterium tuberculosis (drug-resistant)- Lipopolysaccaride + Endo/exotoxins, Mycoplasma hominis, Mycoplasma pneumoniae, Pneumocystis carnii, Prevotella intermedia, Prevotella melaninogenica, Protomyxzoa rheumatica (aka: funneliformis mosseae, Glomus mosseae, FL1953), Pseudomonas aeruginosa, Pseudomonas fluorescens, Serratia marcescens, Staph albus, Staph epidermis, Staph heamolyticus, Staph Saprophyticus, Staph warneri, Staphylococcus aureus, Stenotrophmonas maltophilia, Strep agalaciae, Strep fecalai, Strep moniliformis, Strep mutans, Streptococcus pneumoniae, Streptococcus pyogenes, Tannerella forsythia

Sinusitis • Upper Airway • Bronchitis • Pneumonia • Chronic Lung Disease

Symptom Timing

• Improves then worsens after viral URI (day 5–10) → Haemophilus influenzae, Staphylococcus aureus
• Persistent cough >3 weeks, minimal fever → Mycoplasma pneumoniae, Chlamydia pneumoniae, Bordetella pertussis
• Slow, progressive symptoms over months → NTM (MAC, M. abscessus, M. kansasii), Mycobacterium tuberculosis

Fever & Systemic Toxicity

• High fever, confusion, hyponatremia → Legionella pneumophila
• Severe pneumonia with hemoptysis, weight loss → Mycobacterium tuberculosis
• Rapid deterioration post-influenza → Staphylococcus aureus

Host & Exposure Clues

• COPD / smoker → H. influenzae, Pseudomonas aeruginosa
• Bronchiectasis / CF → Pseudomonas, Burkholderia cepacia complex, NTM
• Hospitalized / devices / irrigations → Pseudomonas, Serratia, Enterobacter
• Dental disease / aspiration risk → Prevotella spp.
• Water exposure (hotels, HVAC, showers) → Legionella
• Animal / soil exposure (regional) → Francisella tularensis, Burkholderia pseudomallei

Diagnostic Pattern Clues

• Negative routine cultures, PCR positive → Mycoplasma, Chlamydia, Bordetella
• AFB positive, slow growth → TB or NTM
• Biofilm behavior / antibiotic failure → S. aureus, Pseudomonas

Tier 1 — Primary Sinus Pathogens

• Haemophilus influenzae Most common bacterial sinusitis cause; post-viral “double worsening”
• Staphylococcus aureus Key driver of chronic rhinosinusitis (CRS); biofilm-mediated persistence
• Prevotella melaninogenica
• Prevotella intermedia Anaerobic inflammation; odontogenic and chronic sinus disease
• Corynebacterium tuberculostearicum CRS-associated dysbiosis marker; pathogenic in select hosts

Tier 2 — Contributory / Context-Dependent

• Mycoplasma pneumoniae – pharyngitis → bronchitis overlap
• Chlamydia pneumoniae – prolonged URI with inflammation
• Bordetella pertussis – early URI mimic, later cough dominance
• Pseudomonas aeruginosa – post-surgical or immunocompromised CRS

Tier 3 — Rare / Secondary Sinus Involvement

• Legionella pneumophila
• Mycobacterium tuberculosis
• NTM (MAC, M. abscessus, M. kansasii)
• Serratia marcescens
• Enterobacter hormaechei
• Francisella tularensis
• Burkholderia pseudomallei
• Bacillus anthracis

Tier 1 — Major LRT Pathogens

• Haemophilus influenzae (COPD exacerbations, pneumonia)
• Mycoplasma pneumoniae (atypical pneumonia)
• Chlamydia pneumoniae (subacute pneumonia)
• Legionella pneumophila (severe pneumonia)
• Staphylococcus aureus (post-viral, necrotizing pneumonia)
• Pseudomonas aeruginosa (bronchiectasis, ICU, CF)
• Mycobacterium tuberculosis (including drug-resistant TB)

Tier 2 — Chronic / Opportunistic

• Mycobacterium avium complex
• Mycobacterium abscessus
• Mycobacterium kansasii
• Burkholderia cepacia complex
• Bordetella pertussis
• Burkholderia pseudomallei

Tier 3 — Colonizers / Secondary Invaders

• Prevotella spp. (aspiration pneumonia)
• Serratia marcescens
• Enterobacter hormaechei
• Staphylococcus epidermidis (“Staph albus”)
• Mycoplasma hominis

Biofilm-Driven

• Staphylococcus aureus + Pseudomonas aeruginosa → CRS, bronchiectasis, antibiotic failure
• Pseudomonas aeruginosa + Burkholderia cepacia complex → Accelerated lung decline (CF)

Anaerobe–Aerobe Cooperation

• Prevotella spp. + Staphylococcus aureus → Chronic sinus inflammation
• Prevotella spp. + Enterobacter/Serratia → Aspiration pneumonia severity

Post-Viral Escalation

• Viral URI → Haemophilus influenzae ± Staphylococcus aureus → “Double worsening” pattern

Structural Lung Disease Amplifier

• Bronchiectasis/COPD → NTM ± Pseudomonas → Progressive chronic infection

 Cardiovascular (Associative)

• Prevotella intermedia
• Tannerella forsythia Periodontal–vascular inflammatory axis
• Chlamydia pneumoniae Biologic plausibility for atherosclerosis

Autoimmune / Immune Dysregulation

• Tannerella forsythia Strong RA–periodontitis association
• Chronic airway colonization (S. aureus, H. influenzae) Th17-skewed inflammation

Cancer-Adjacent Inflammation

• Mycobacterium tuberculosis Increased lung cancer risk via scarring
• Chronic airway inflammation (COPD/bronchiectasis) Inflammatory microenvironment, not direct oncogenesis

• Mycobacteria do NOT produce classic LPS endotoxin → Inflammation driven by mycolic acids & lipoarabinomannan
• Bacillus anthracis disease is toxin-mediated, not endotoxin-based

*This presentation was generated by ChatGPT for educational purposes only, with no endorsement of PhagenCorp or the Inducen formulas implied or suggested. For licensed healthcare professional use and patient education.